Journal of psychoactive drugs
-
J Psychoactive Drugs · Apr 2001
Case ReportsGamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
There is little medical information available about gamma-hydroxybutyrate (GHB) or gamma-butyrolactone (GBL) dependence or withdrawal. In this study the authors treated and reviewed multiple cases of GHB and GBL withdrawal in high-dose users. ⋯ They conclude that patients with GHB or GBL withdrawal may present with agitated psychosis, delirium, and autonomic instability. In this sample, relapse to GHB or GBL use occurred soon after treatment of withdrawal.